beem stock forecast zacks

Wednesday, October 5, 2022 Edit

Click here - the BEEM analysis is free About. The forecasts range from a low of 6000 to a high of.

A Complete Ev Charging Stocks List Learn More Investment U

View Beam Therapeutics Inc BEAM investment stock information.

. Looking for stock market analysis and research with proves results. Beam Global - Sell. In the short term 2weeks BEEMs stock price.

Beam Global BEEM came out with a quarterly loss of 022 per share versus the Zacks Consensus Estimate of a loss of 020. In fact when combining a Zacks Rank 3 or better and a positive Earnings ESP stocks produced a positive surprise 70 of the time while they also saw 283 annual. BEEM stock forecast Our latest prediction for Beam Globals stock price was made on the April 4 2022 when the stock price was at 2330.

According to 13 analysts the average rating for BEEM stock is Buy The 12-month stock price forecast is 2652 which is an increase of 10306 from the latest price. Do the numbers hold clues to what lies ahead. Zacks proprietary data indicates that Beam Global is currently rated as a Zacks Rank 4 and we are expecting a below average return from the BEEM shares relative to.

Looking at the full year our Zacks Consensus Estimates suggest analysts are expecting earnings of -066 per share and revenue of 1736 million. These results would represent year-over-year changes of. Zacks Investment Research is releasing its prediction for BEEM based on the 1-3 month trading system that nearly triples the SP 500.

Based on short-term price targets offered by five analysts the average price target for Beam Global comes to 2600. Based on short-term price targets offered by eight analysts the average price target for Beam Therapeutics Inc. This compares to loss of 034 per share a year.

Beam Global - BEEM Stock Forecast Price News 1291 013 102 As of 09282022 0117 PM ET Todays Range 1289 1302 50-Day Range 1231 1783 52. The forecasts range from a low of 1700 to a high of. Find the latest Revenue TTM for Beam Global BEEM.

BEEMs full-year Zacks Consensus Estimates are calling for earnings of -066 per share and revenue of 1793 million. Revenue TTM is a widely used stock evaluation measure. Get the latest Beam Therapeutics Inc BEAM detailed stock quotes stock data Real-Time ECN charts.

The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 8800 with a high estimate of 14500 and a low estimate of 6000. By Zacks Equity Research Published on August 122022 Beam Global BEEM delivered earnings and revenue surprises of -4737 and 1714 respectively for the quarter. Beam Global BEEM delivered earnings and revenue surprises of -4737 and 1714 respectively for the quarter ended June 2022.

Beam Global Beem Stock Latest News Beem News Today